Completed EUCTR 2008-006738-85
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United Kingdom Schizophrenia Drug i A study involving a medication or substance.
Countries United Kingdom
Sponsor Azur Pharma, Ltd.
Condition Schizophrenia Terminated NCT05109195
This study was terminated in the United States and in the United Kingdom. It focuses on depression.
In United Kingdom Depression Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 74 Years
Countries United States, United Kingdom
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT05633108
This study is completed in the United Kingdom. It focuses on Schizophrenia.
In United Kingdom Schizophrenia Observational Over 18 Years
Countries United Kingdom
Sponsor Eisai Co., Ltd.
Condition Schizophrenia Completed NCT00447278
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In United Kingdom ADHD Behavioral From 6 Years to 16 Years
Countries France, United Kingdom, Belgium, ...
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT05841030
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In United Kingdom Depression Observational From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT00300846
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing treatment of Aripiprazole for Schizophrenia.
In United Kingdom Schizophrenia Drug From 18 Years to 65 Years
Countries France, United Kingdom, Switzerland, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT05550532
This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In United Kingdom Depression Drug From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Terminated NCT05518149
This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
In United Kingdom Depression Drug From 18 Years to 74 Years
Countries United States, Australia, France, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT02006628
This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.
In United Kingdom Schizophrenia Drug From 18 Years to 65 Years
Countries United Kingdom, Poland, Romania
Sponsor Jazz Pharmaceuticals
Condition Schizophrenia Completed NCT04080752
This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-61393215 for depression.
In United Kingdom Depression Drug From 18 Years to 64 Years
Countries United States, United Kingdom, Moldova, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT05029401
This study is completed in the United Kingdom. It is testing ibogaine for Addiction.
In United Kingdom Addiction Drug From 18 Years to 55 Years
Countries United Kingdom
Sponsor atai Therapeutics, Inc.
Condition Addiction Completed NCT00216476
This study is completed in France, in the United Kingdom, in Austria, .... It is testing Long-acting Injectable Risperidone and Quetiapine Tablets for schizophrenia.
In United Kingdom Schizophrenia Drug Over 18 Years
Countries France, United Kingdom, Austria, ...
Sponsor Janssen-Cilag International NV
Condition Schizophrenia